SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-20-005728
Filing Date
2020-10-05
Accepted
2020-10-05 08:16:20
Documents
4
Period of Report
2020-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm 8-K 22545
2 AGREEMENT AND PLAN OF MERGER curr_ex21.htm EX-2.1 749737
3 LOCK UP AGREEMENT curr_ex101.htm EX-10.1 25772
4 EMPLOYMENT AGREEMENT curr_ex102.htm EX-10.2 47152
  Complete submission text file 0001477932-20-005728.txt   846694
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 201222361
SIC: 2673 Plastics, Foil & Coated Paper Bags